SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate
Monohydrate IP Eq to Sitagliptin 50mg + Metformin Hydrochloride IP
1000mg
Description
SITAMATA 50-1000 contains Sitagliptin 50 mg + Metformin Hydrochloride 1000 mg, a strong dual-action combination designed for better control of type 2 diabetes. Sitagliptin helps the body release insulin more effectively after meals, while Metformin lowers excess glucose production and improves insulin sensitivity. This combination supports stable blood sugar management, better HbA1c control, and long-term diabetes care in adult patients.
Related products
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
MUCINIL TAB
COMPOSITION : N acetyl cysteine 150 mg and taurine 500 mg
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively....
DUET ACT 4 FORTE
DUET ACT 4 FORTE Tablet is a combination medicine used for managing type 2 diabetes...
CARBOSTOP 25
CARBOSTOP 25 Tablet is a combination medicine used to manage type 2 diabetes. It contains...
Metix-1000
Composition: Metformin Hydrochloride Sustained Release I.P. 1000 mg (Metformin SR 1000mg)
Metix-500
Composition : Metformin 500mg
